J, T., B, H., L, M., S, B., C, N., & B, C. (2023). Tolerability and efficacy of chemoimmunotherapy when administered with a corticosteroid-free anti-emetic regimen. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 29(7), 1661. https://doi.org/10.1177/10781552221146528
Chicago Style (17th ed.) CitationJ, Tieri, Harris B, Melikian L, Bullington S, Naville-Cook C, and Crawford B. "Tolerability and Efficacy of Chemoimmunotherapy When Administered with a Corticosteroid-free Anti-emetic Regimen." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners 29, no. 7 (2023): 1661. https://doi.org/10.1177/10781552221146528.
MLA (9th ed.) CitationJ, Tieri, et al. "Tolerability and Efficacy of Chemoimmunotherapy When Administered with a Corticosteroid-free Anti-emetic Regimen." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, vol. 29, no. 7, 2023, p. 1661, https://doi.org/10.1177/10781552221146528.